In this week’s edition of InnovationRx, we look at Sarepta’s showdown with the FDA, Moderna’s use of quantum computers, a new top drug regulator at the FDA, ARCH Venture’s latest biotech company, and more. To get it in your inbox, subscribe here.
Sarepta Therapeutics CEO Douglas Ingram
Continue Reading